Wantai Bio's actual controller Zhong Shanshan has completed the transfer registration of 33 million unrestricted tradable shares donated free of charge to the Fujian Xiang'an Innovation Laboratory Science and Technology Development Foundation. The combined shareholding of Zhong and his concert party Yangshengtang Co., Ltd. in the listed company has fallen from 73.53% to 70.92%, with the equity change reaching the 1% threshold. The donated shares account for 2.61% of the company's total share capital. After the transfer, Zhong's direct shareholding decreased from 223,951,071 shares to 190,951,071 shares, with his stake falling from 17.71% to 15.10%, while Yangshengtang's shareholding remains unchanged. The announcement stated that this equity change does not trigger a mandatory tender offer and will not lead to a change in the controlling shareholder or actual controller. Wantai Bio achieved operating revenue of 1.048 billion yuan in the first half of the year, up 24.29% year on year, while net profit attributable to the parent company was negative 128 million yuan, with losses narrowing. The revenue growth was mainly driven by the ramp-up of the nine-valent HPV vaccine after its launch. As of the close on September 4, the company's share price stood at 27.67 yuan, with a cumulative decline of about 38.43% since the beginning of 2026.
Beijing Wantai Biological Pharmacy Enterprise Co LtdDonation of shares reduces controlling stake but no change in control; financials show revenue growth but net loss.
As concert party, stake reduction affects combined holding but no direct operational impact.
